All posts
Readmissions
Hana Health
August 10, 2026

Why Do Patients Ignore Your Follow-Up Messages?

I built a mental health app for bipolar patients once. Beautiful thing, honestly. Mood tracking, medication reminders, a whole design system I was weirdly proud of. Fifteen percent of patients used it weekly.

Fifteen.

We shipped updates for months. Better onboarding, push notifications, gamification, the whole playbook. The number didn't move. And I kept telling myself the product needed one more iteration, because that's what you tell yourself when you've spent two years building something and the data is quietly explaining that you built the wrong thing entirely.

Then we tried calling patients instead. With AI, because we couldn't afford nurses. Engagement went to 85%.

That's the origin story of HANA, and I still think about it every time somebody shows me a patient engagement dashboard with a flat line on it.

Why do patients ignore digital follow-up?

Because the effort sits on them. Every text message, portal login, and app notification is a small ask: stop what you're doing, remember your password, interpret a question, type an answer. Sick people recovering from a hospital stay have a limited budget for that kind of work, and they spend it on whatever feels urgent.

A phone call inverts the ask. Somebody comes to you. You talk, which humans do without effort. The interaction ends when the conversation ends.

That's not a UX insight. It's a physics one.

What does the research actually say about mHealth engagement?

It says the engagement problem is real and it's the bottleneck. A 2026 secondary analysis in JMIR looked at patients enrolled in an automated post-discharge SMS program who ended up back in the hospital within 30 days. Fewer than half of them had engaged with the messaging at all before they returned.

Read that again. The outreach program existed. The messages went out. The patients who needed it most weren't in the conversation.

The parent trial, MORE-PC, found no significant reduction in 30-day readmissions. And the detail that should worry every clinic running a texting program: an earlier pilot of the same intervention showed a 55% drop in readmission odds. Pilot worked. Trial didn't. The difference wasn't the technology.

Is the problem the channel or the effort?

The effort. Always the effort.

I learned this in a circus, of all places. I crossed the Australian desert with one in my twenties (feels like another lifetime, honestly), and the acts drawing the biggest crowds weren't the technically hardest ones. Aerial silk takes years. Fire chains take months. The fire chains won every night, in every town, because you could stand there with a beer and get it immediately.

Accessible beats impressive. In a dusty field outside Coober Pedy, and in post-discharge care.

That same JMIR analysis found mHealth users skewed younger and commercially insured, which is a polite way of saying the tool worked best for the people least likely to bounce back. That isn't engagement. That's selection.

What changes when you call instead of text?

The floor moves. Across 1M+ patient interactions we see roughly 85% weekly engagement against an industry baseline sitting around 15 to 20%. Same patients. Same clinical questions. Different demand on the patient.

Voice also carries information text can't. Somebody typing "fine" and somebody saying "fine" after a three second pause are two different clinical situations, and only one of them is legible in a chat log. Our post-discharge and chronic care workflows escalate on hesitation, confusion, and symptom language, not just on the answer given.

And it scales, which nurse-led calling never did. That's the constraint the JMIR authors keep circling: phone outreach works, staffing kills it. Transitional care management has been reimbursable for years. Most practices still can't run it at volume, because the bottleneck was never the billing code, it was a nurse with a list and four hours.

How should clinics measure engagement?

Stop measuring sends. Measure conversations completed, per patient, per week.

Delivery rates and open rates are vanity numbers dressed as clinical ones. If you run a post-discharge program, the figure that matters is what fraction of enrolled patients actually said something back to you in the last seven days, and whether that fraction holds for your Medicare population as well as your commercial one. Most programs never split that cohort. When they do, the number usually falls apart.

Then run the second cut, which almost nobody does: engagement by risk tier. If your highest-risk quartile engages at half the rate of your lowest, your program is spending its entire budget on the patients who were going to be fine anyway. That's not a small inefficiency. That's the intervention pointing backwards.

We publish ours, along with deployment results from live clinics, because the industry habit of reporting messages sent has done real damage.

Key Takeaways

Patient engagement isn't a content problem or a channel problem. It's an effort problem, and every digital tool requiring the patient to initiate is quietly selecting for the healthiest, youngest, most connected slice of your panel. The research shows engagement gaps concentrate exactly where readmission risk concentrates. If your follow-up program reports on messages sent rather than conversations held, you don't have an engagement number, you have a marketing one. And if you're about to spend another quarter iterating on an app nobody opens, I'd gently suggest you're standing where I stood in 2019, and the answer isn't another sprint.

FAQ

Does AI voice follow-up actually reduce readmissions? The mechanism is early detection: catching symptom changes, medication confusion, and missed follow-up appointments in the window where intervention is still cheap. Engagement is the prerequisite, not the outcome. If patients aren't talking to you, no detection layer helps.

Is voice AI safe for post-discharge patients? It depends entirely on escalation design. Across more than a million interactions we've recorded zero critical adverse events, which comes from strict scope limits and clinician handoff triggers rather than from the model being clever. Our technical docs cover the escalation architecture.

What about patients who don't want to talk to a machine? Some don't, and they should get a human. The useful question isn't whether AI outreach is universally preferred, it's whether it raises the floor for patients currently getting no outreach at all. Most clinics are staffed to call maybe a fifth of their discharges.

If you're running a follow-up program and the engagement number embarrasses you, book a call with me and we can look at it together. I've been on that side of the dashboard.